Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
33 participants
INTERVENTIONAL
2010-03-31
2013-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Probiotics In Colorectal Cancer Patients
NCT00936572
Probiotics in the Prevention of Complications After Colorectal Surgery
NCT02313519
Comparison of Probiotic Effects on the Outcomes of Patients After Colorectal Cancer Surgery
NCT07144475
Probiotics and Recovery From Gastrointestinal Surgery - 2
NCT04266106
The Impact of Probiotics on Bariatric Treatment Outcomes
NCT07258732
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
No intervention at all
No interventions assigned to this group
Study group
Use of Saccharomyces boulardii, 100mg for at least seven days before surgery
Saccharomyces boulardii
100mg daily for seven days prior to surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Saccharomyces boulardii
100mg daily for seven days prior to surgery
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* intend to undergo elective colon resection at the UFMG Hospital
Exclusion Criteria
* Patients unable to receive the probiotics for, at least, 7 days before the operation
* Changes to the operation strategy
* Patients that discontinued probiotic use
* Patients who had previously taken any probiotic or prebiotic
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of Minas Gerais
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maria Isabel Toulson Davisson Correia
Professor of Surgery, responsible investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria Isabel Correia, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
UFMG
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CDS - APQ-01005-11
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
CDS - APQ-01005-11
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.